Skip to content

Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) Protocol

A Comprehensive Enhanced Recovery After Surgery (ERAS) Protocol for Thyroidectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07575243
Enrollment
143
Registered
2026-05-08
Start date
2024-05-01
Completion date
2025-05-31
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Diseases, Goiter, Thyroid Neoplasms

Keywords

Enhanced recovery after surgery, ERAS, Multimodal perioperative care, Length of hospital stay, Thyroidectomy, Opioid-sparing multimodal analgesia

Brief summary

Thyroidectomy is generally considered a low-to-moderate risk operation; however, postoperative pain, nausea/vomiting, and prolonged hospital stays remain common issues. Enhanced Recovery After Surgery (ERAS) pathways aim to optimize perioperative care and accelerate recovery. This study evaluates the effectiveness and safety of a standardized ERAS pathway in patients undergoing elective thyroidectomy. The prospective ERAS cohort is compared with a historical control group receiving conventional care to assess the impact on the length of hospital stay, postoperative pain, opioid consumption, and complication rates.

Interventions

This incorporates standardized preoperative counseling, reduced fasting, multimodal opioid-sparing analgesia, total intravenous anesthesia, selective drain use, early oral intake and mobilization, and PTH-guided calcium supplementation

PROCEDUREConventional perioperative care

This often involves prolonged preoperative fasting, opioid-based analgesia, and delayed mobilization

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-75 years * ASA physical status I-III. * Scheduled for elective thyroidectomy for benign or malignant disease.

Exclusion criteria

* Re-operative thyroid surgery * Concomitant neck dissection * Inability to comply with the ERAS pathway

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayUp to 30 days post-surgeryHours from surgery end to discharge

Secondary

MeasureTime frameDescription
Postoperative pain scoresAssessed in the first 24 hours postoperativelyMean Numeric Rating Scale (NRS-11; 0 = no pain to 10 = worst imaginable pain) at rest in 24 hours. NRS scores are categorized as mild (1-3), moderate (4-6), or severe (7-10).
Total opioid consumptionWithin first 24 hoursOral Morphine Milligram Equivalents (MME)
Postoperative nausea and vomiting (PONV)Up to 24 hours postoperativelyIncidence of PONV
Rate of postoperative hypocalcemiaFirst 30 days from the surgeryBiochemical and symptomatic occurrences
30-day unplanned readmission rateUp to 30 days postoperativeNumber of unplanned readmissions

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026